| |
| |
|
| Insider
Information: |
Bilenker Joshua H. |
| Relationship: |
|
| City: |
Warren |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
38,964 |
|
|
Indirect Shares
|
7,461,923 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$7 |
|
|
| Total
Shares |
7,500,887 |
|
|
| Total
Value |
$7 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Loxo Oncology, Inc. |
LOXO |
President & CEO, Direc... |
2019-02-15 |
0 |
2019-02-15 |
0 |
Premium* |
|
|
Viewray, Inc. |
VRAY |
Director, 10% Owner |
2016-09-13 |
18,964 |
2016-09-13 |
7,461,923 |
Premium* |
|
|
Sana Biotechnology, Inc. |
SANA |
|
2021-02-03 |
20,000 |
2021-02-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LOXO |
Loxo Oncology, Inc. |
President & CEOOfficer |
• • – |
2014-07-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
188,707 |
|
- |
|
| VRAY |
Viewray, Inc. |
Director |
– • • |
2016-03-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,461,923 |
|
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2001-10-03 |
4 |
AS |
$165.01 |
$479,342 |
D/D |
(2,905) |
142,502 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2018-06-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
127,707 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-11-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
182,707 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2018-10-03 |
4 |
AS |
$165.95 |
$1,193,254 |
D/D |
(7,095) |
135,407 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-08-14 |
4 |
OE |
$1.18 |
$8,880 |
D/D |
7,500 |
196,207 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-08-14 |
4 |
AS |
$73.54 |
$553,006 |
D/D |
(7,500) |
188,707 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-08-15 |
4 |
AS |
$73.33 |
$550,443 |
D/D |
(7,500) |
188,707 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-08-15 |
4 |
OE |
$1.18 |
$8,880 |
D/D |
7,500 |
196,207 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-09-18 |
4 |
AS |
$87.93 |
$669,406 |
D/D |
(7,500) |
188,707 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-09-18 |
4 |
OE |
$1.18 |
$8,880 |
D/D |
7,500 |
196,207 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-09-19 |
4 |
AS |
$87.82 |
$665,870 |
D/D |
(7,500) |
188,707 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-09-19 |
4 |
OE |
$1.18 |
$8,880 |
D/D |
7,500 |
196,207 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-10-30 |
4 |
OE |
$1.18 |
$8,880 |
D/D |
7,500 |
196,207 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-10-30 |
4 |
AS |
$86.88 |
$653,967 |
D/D |
(7,500) |
188,707 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-10-31 |
4 |
AS |
$86.18 |
$648,702 |
D/D |
(7,500) |
188,707 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-10-31 |
4 |
OE |
$1.18 |
$8,880 |
D/D |
7,500 |
196,207 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-11-27 |
4 |
OE |
$1.18 |
$8,880 |
D/D |
7,500 |
190,207 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-11-27 |
4 |
AS |
$74.13 |
$560,100 |
D/D |
(7,500) |
182,707 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-11-28 |
4 |
OE |
$1.18 |
$8,880 |
D/D |
7,500 |
190,207 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-11-28 |
4 |
AS |
$73.15 |
$556,648 |
D/D |
(7,500) |
182,707 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-12-14 |
4 |
OE |
$1.18 |
$8,880 |
D/D |
7,500 |
190,207 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-12-14 |
4 |
AS |
$82.55 |
$625,120 |
D/D |
(7,500) |
182,707 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
President & CEO |
• • – |
2017-12-15 |
4 |
OE |
$1.18 |
$8,880 |
D/D |
7,500 |
190,207 |
0 |
- |
|
80 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
